GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (NAS:FBIOP.PFD) » Definitions » Total Operating Expense

FBIOP.PFD (Fortress Biotech) Total Operating Expense : $144.40 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Fortress Biotech Total Operating Expense?

Fortress Biotech's Total Operating Expense for the three months ended in Sep. 2024 was $31.44 Mil. Fortress Biotech's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was $144.40 Mil.

Fortress Biotech Total Operating Expense Historical Data

The historical data trend for Fortress Biotech's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortress Biotech Total Operating Expense Chart

Fortress Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 136.92 125.28 215.71 248.53 200.20

Fortress Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.08 36.69 42.78 33.49 31.44

Fortress Biotech Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $144.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortress Biotech Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Fortress Biotech's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortress Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (NAS:FBIOP.PFD) » Definitions » Total Operating Expense
Comparable Companies
SYBX GLTO NNVC SNSE VBIV AXLA QSAM CNTX NRBO COCP OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
FBIO:USA CNB0.PFD:Germany
Address
1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154
Website
https://www.fortressbiotech.com
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.